BIIB
Biogen Stock Analysis
AI Rating
- Quality7/10
- Growth↑ 5/10
- Value↓ 3/10
BIIB Growth
- Revenue Y/Y↓ 0.97%
- EPS Y/Y↓ -7.97%
- FCF Y/Y↓ 0.72%
BIIB Profitability
- Gross margin ↑ 75.50%
- EPS margin↑ 13.80%
- ROIC 5Y↓ 12.74%
BIIB Risk
- Debt / Equity↓ 0.4
- Debt / FCF↓ 1.3
- Interest coverage↓ NA
Biogen stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.